Share on Pinterest The Food and Drug Administration (FDA) recently approved a tablet version of the GLP-1 drug Wegovy for weight loss. Image courtesy of Novo Nordisk Novo Nordisk officials said a new ...

Some tout a daily semaglutide pill as a game-changer for weight-loss treatment. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo ...

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug. The Wegovy pill, as it’s called, is first oral version of a GLP-1 drug that ...

JACKSONVILLE, Fla. – If you’ve ever driven over the Mathews Bridge that connects downtown Jacksonville to the Arlington neighborhood, then you’ve likely seen some beautiful views of the city from high ...

By converting Robinson-Earl to a standard contract, Indiana clears the path for Mathews to take the hardship slot. Robinson-Earl has appeared in 10 games and made three starts, averaging 5.2 points ...

Mathews Archery dove into the world of no-bow-press-needed tuning features last year by introducing Limb Shift Technology on its Lift X bows. It’s simple to use by bowhunters everywhere, and sales of ...

Blame it on return-to-office policies or fashion’s current romance with the ’80s, but pussy bows—one of the most controversial (and, it must be said, chicest) design flourishes in recent memory—are ...

Fintel reports that on October 7, 2025, Morgan Stanley maintained coverage of Bowhead Specialty Holdings (NYSE:BOW) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 53.73% Upside As ...

Weight loss medications may help adults who are ages 65 years or older improve their health and manage obesity-related conditions. The benefits and risks depend on the drug, your overall health, and ...

The New York Knicks could look to upgrade their bench by signing former Atlanta Hawks guard Garrison Mathews. Bleacher Report writer Eric Pincus listed Mathews as the eighth-best minimum contract ...

Operator: Good day, and thank you for standing by. Welcome to the South Bow Quarter 2 Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now ...

Eli Lilly delivered strong Q2 results, raising full-year guidance, but shares plunged over 15% due to underwhelming Orforglipron weight loss data. Tirzepatide's explosive growth cements Lilly's ...